EX
Exelixis
EXEL · NASDAQ
$59.01 +0.87% (+$0.51)
1M +9.14%
Market Cap $14.9B
P/E Ratio 17.27x
Div. Yield -
ROE 42.49%
Bulios Fair Price
$88.5
50.0% upside
Trenutna cena
$59.01
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica EXEL trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
63 /100
Fair P/E 17.27x
EV/EBITDA 14.18x
P/S 6.10x
Growth
83 /100
Growing EPS growth 70.59%
Rev. growth 12.93%
FCF growth 55.59%
Profitability
100 /100
Strong Gross margin 96.48%
Net margin 35.33%
Op. margin 39.88%
Quality
97 /100
Excellent ROIC 37.87%
ROE 42.49%
ROA 34.50%
Debt
100 /100
Low Debt/Equity 0.09x
Current ratio 3.46x
Net debt/EBITDA -0.11x
Stability
59 /100
Moderate Beta 0.42x
Rev. volatility 5.78%
EPS volatility 80.01%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o EXEL
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Michael Morrissey
Employees
1,077
Headquarters
Alameda
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report